Business Context and Reporting Period
cbdMD, Inc. filed a Form 8-K Current Report on December 16, 2022. The company is incorporated in North Carolina and trades on the NYSE American under the symbols YCBD (Common Stock) and YCBDpA (8.0% Series A Cumulative Convertible Preferred Stock). The filing reports a specific corporate event regarding preferred stock dividends.
Key Financial Metrics
This filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to a dividend declaration:
- Dividend Amount: $0.0667 per share of 8.0% Series A Cumulative Convertible Preferred Stock.
- Record Date: January 3, 2022.
- Payment Date: January 17, 2022.
Material Changes
The filing reports the declaration of a monthly cash dividend for the Series A Convertible Preferred Stock. No material changes to operations, revenue, or balance sheet items are disclosed in this specific report.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document is limited to the notification of the dividend event under Item 8.01 (Other Events).
Key Facts for Investor Verification
- Verify the record date (January 3, 2022) and payment date (January 17, 2022) for the $0.0667 per share dividend on Series A Preferred Stock.
- Confirm the company's status as an emerging growth company, as indicated in the filing.
- Note that this 8-K does not contain quarterly or annual financial performance data; refer to 10-Q or 10-K filings for revenue and profit metrics.